Missing/wrong data?
Log in to edit
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
scientific article published on 3 May 2022
Author/s
author: Daria Handkiewicz-Junak, Aleksandra Syguła, Aleksandra Ledwoń, Kornelia Hasse-Lazar, Beata Jurecka-Lubieniecka, Barbara Michalik, Ewa Paliczka-Cieslik, Ewa Chmielik, Barbara Jarząb
Work details
Publication date
May 3, 2022
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.